Pharmacists in Flagler Beach, Florida


13 Pharmacists found in Flagler Beach
female pharmacist

Amber Monee Pinnock, RPH


Pharmacist
2301 Moody Blvd, Flagler Beach, FL 32136
386-439-0271    

male pharmacist

Dr. Benjamin Kenneth Reagh, PHARM D


Pharmacist
2301 Moody Blvd, Flagler Beach, FL 32136
386-439-0271    

male pharmacist

Charles Traubert, R.PH.


Pharmacist
2301 Moody Blvd, Flagler Beach, FL 32136
386-439-0271    



female pharmacist

Dr. Charlotte Jung, PHARMD


Pharmacist
414 Beach Village Dr, Flagler Beach, FL 32136
386-517-2781    

female pharmacist

Heather Taylor


Pharmacist
2301 Moody Blvd, Flagler Beach, FL 32136
386-439-6271    

female pharmacist

Holly Tarantola


Pharmacist
10 Wilderness Run, Flagler Beach, FL 32136
386-793-3395    

male pharmacist

Mr. James S Tarantola, RPH


Pharmacist
10 Wilderness Run, Flagler Beach, FL 32136
386-439-3724    

male pharmacist

Jan Derby, R.PH.


Pharmacist
414 Beach Village Dr, Flagler Beach, FL 32136
386-517-2781    

female pharmacist

Lisa Waite


Pharmacist
414 Beach Village Dr, Flagler Beach, FL 32136
386-517-2781    

male pharmacist

Long Phi Bui, PHARMD


Pharmacist
414 Beach Village Dr, Flagler Beach, FL 32136
386-517-2776    

male pharmacist

Mr. Prashant K Patel, MS, MBA, R PH


Pharmacist
200 Moody Blvd, Flagler Beach, FL 32136
904-728-7283     386-426-6600

female pharmacist

Tina Hieu Nguyen


Pharmacist
2301 Moody Blvd, Flagler Beach, FL 32136
386-439-0271    

male pharmacist

Dr. William Edward Starke, BILL STARKE


Pharmacist
9 Bulow Woods Cir, Flagler Beach, FL 32136
386-439-9724    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.